Malignant catatonia responsive to low doses of lorazepam: case report
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | São Paulo medical journal (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802016000200176 |
Resumo: | Abstract CONTEXT: Catatonia can be divided into non-malignant or malignant. The latter is characterized by autonomic instability, exhibiting high fever, tachycardia and hypertension, and is regarded as a fulminant and rapidly progressive subtype. CASE REPORT: This article reports a case of malignant catatonia in a 43-year-old patient who had been presenting psychiatric disorders for the last three years. The patient was stable, maintaining mutism, immobility and autonomic abnormalities. Oral lorazepam (1 mg every eight hours) was introduced and, in a few hours, the patient became afebrile. Two days later, the patient was already responding to verbal commands. CONCLUSIONS: Early intervention with lorazepam reduced the evolution of this patient to a fatal complication. Therefore, this case report sought to show that early diagnosis and intervention reduced the occurrence of serious and irreversible clinical outcomes. |
id |
APM-1_a84f4d164b6cbbca2968d4791c7749d9 |
---|---|
oai_identifier_str |
oai:scielo:S1516-31802016000200176 |
network_acronym_str |
APM-1 |
network_name_str |
São Paulo medical journal (Online) |
repository_id_str |
|
spelling |
Malignant catatonia responsive to low doses of lorazepam: case reportCatatoniaBenzodiazepinesLorazepamDepressive disorderCase reportsAbstract CONTEXT: Catatonia can be divided into non-malignant or malignant. The latter is characterized by autonomic instability, exhibiting high fever, tachycardia and hypertension, and is regarded as a fulminant and rapidly progressive subtype. CASE REPORT: This article reports a case of malignant catatonia in a 43-year-old patient who had been presenting psychiatric disorders for the last three years. The patient was stable, maintaining mutism, immobility and autonomic abnormalities. Oral lorazepam (1 mg every eight hours) was introduced and, in a few hours, the patient became afebrile. Two days later, the patient was already responding to verbal commands. CONCLUSIONS: Early intervention with lorazepam reduced the evolution of this patient to a fatal complication. Therefore, this case report sought to show that early diagnosis and intervention reduced the occurrence of serious and irreversible clinical outcomes.Associação Paulista de Medicina - APM2016-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802016000200176Sao Paulo Medical Journal v.134 n.2 2016reponame:São Paulo medical journal (Online)instname:Associação Paulista de Medicinainstacron:APM10.1590/1516-3180.2014.00052608info:eu-repo/semantics/openAccessMatias,Diego Fernando MoreiraAndo,Sabrina de MelloRiera,RachelGóis,Aécio Flávio Teixeira deeng2016-05-19T00:00:00Zoai:scielo:S1516-31802016000200176Revistahttp://www.scielo.br/spmjhttps://old.scielo.br/oai/scielo-oai.phprevistas@apm.org.br1806-94601516-3180opendoar:2016-05-19T00:00São Paulo medical journal (Online) - Associação Paulista de Medicinafalse |
dc.title.none.fl_str_mv |
Malignant catatonia responsive to low doses of lorazepam: case report |
title |
Malignant catatonia responsive to low doses of lorazepam: case report |
spellingShingle |
Malignant catatonia responsive to low doses of lorazepam: case report Matias,Diego Fernando Moreira Catatonia Benzodiazepines Lorazepam Depressive disorder Case reports |
title_short |
Malignant catatonia responsive to low doses of lorazepam: case report |
title_full |
Malignant catatonia responsive to low doses of lorazepam: case report |
title_fullStr |
Malignant catatonia responsive to low doses of lorazepam: case report |
title_full_unstemmed |
Malignant catatonia responsive to low doses of lorazepam: case report |
title_sort |
Malignant catatonia responsive to low doses of lorazepam: case report |
author |
Matias,Diego Fernando Moreira |
author_facet |
Matias,Diego Fernando Moreira Ando,Sabrina de Mello Riera,Rachel Góis,Aécio Flávio Teixeira de |
author_role |
author |
author2 |
Ando,Sabrina de Mello Riera,Rachel Góis,Aécio Flávio Teixeira de |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Matias,Diego Fernando Moreira Ando,Sabrina de Mello Riera,Rachel Góis,Aécio Flávio Teixeira de |
dc.subject.por.fl_str_mv |
Catatonia Benzodiazepines Lorazepam Depressive disorder Case reports |
topic |
Catatonia Benzodiazepines Lorazepam Depressive disorder Case reports |
description |
Abstract CONTEXT: Catatonia can be divided into non-malignant or malignant. The latter is characterized by autonomic instability, exhibiting high fever, tachycardia and hypertension, and is regarded as a fulminant and rapidly progressive subtype. CASE REPORT: This article reports a case of malignant catatonia in a 43-year-old patient who had been presenting psychiatric disorders for the last three years. The patient was stable, maintaining mutism, immobility and autonomic abnormalities. Oral lorazepam (1 mg every eight hours) was introduced and, in a few hours, the patient became afebrile. Two days later, the patient was already responding to verbal commands. CONCLUSIONS: Early intervention with lorazepam reduced the evolution of this patient to a fatal complication. Therefore, this case report sought to show that early diagnosis and intervention reduced the occurrence of serious and irreversible clinical outcomes. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-04-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802016000200176 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802016000200176 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1516-3180.2014.00052608 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
publisher.none.fl_str_mv |
Associação Paulista de Medicina - APM |
dc.source.none.fl_str_mv |
Sao Paulo Medical Journal v.134 n.2 2016 reponame:São Paulo medical journal (Online) instname:Associação Paulista de Medicina instacron:APM |
instname_str |
Associação Paulista de Medicina |
instacron_str |
APM |
institution |
APM |
reponame_str |
São Paulo medical journal (Online) |
collection |
São Paulo medical journal (Online) |
repository.name.fl_str_mv |
São Paulo medical journal (Online) - Associação Paulista de Medicina |
repository.mail.fl_str_mv |
revistas@apm.org.br |
_version_ |
1754209264821338112 |